Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Cardiopulmonary Bypass Equipment Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Cardiopulmonary Bypass Equipment Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-09-11
Pages: 135 Pages
Report ld: 5038611
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Cardiopulmonary Bypass Equipment Market Size(US$)
CAGR 2025-2031
9.7%
Market Size,2031
USD 959
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 550 million
Market Forecast in 2031(Value)
US$ 959 million
CAGR
9.7%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Cardiopulmonary Bypass Equipment market is projected to grow from US$ 506 million in 2024 to US$ 959 million by 2031, at a CAGR of 9.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Cardiopulmonary Bypass Equipment is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The Cardiopulmonary Bypass Equipment is also called a heart-lung machine. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Global Cardiopulmonary Bypass Equipment key players include Sorin, MAQUET, Medtronic, Terumo CV Group, Braile Biomedica, etc. Global top five manufacturers hold a share about 95%.
North America is the largest market, with a share over 40%, followed by Europe and Asia (ex. China), both have a share over 40%.
In terms of product, Single Roller Pump HLM is the largest segment, with a share over 65%. And in terms of application, the largest application is Cardiac Surgery, followed by Acute Respiratory Failure Treatment, Lung Transplant Operation, etc.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Cardiopulmonary Bypass Equipment market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Sorin
- MAQUET
- Medtronic
- Terumo
- Braile Biomedica
- Tianjin Medical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Single Roller Pump Cardiopulmonary Bypass Equipment
- Double Roller Pump Cardiopulmonary Bypass Equipment
Segment by Application
- Cardiac Surgery
- Lung Transplant Operation
- Acute Respiratory Failure Treatment
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Cardiopulmonary Bypass Equipment study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Cardiopulmonary Bypass Equipment: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Cardiopulmonary Bypass Equipment Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Single Roller Pump Cardiopulmonary Bypass Equipment
1.2.3 Double Roller Pump Cardiopulmonary Bypass Equipment
1.3 Market Segmentation by Application
1.3.1 Global Cardiopulmonary Bypass Equipment Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Cardiac Surgery
1.3.3 Lung Transplant Operation
1.3.4 Acute Respiratory Failure Treatment
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cardiopulmonary Bypass Equipment Revenue Estimates and Forecasts 2020-2031
2.2 Global Cardiopulmonary Bypass Equipment Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Cardiopulmonary Bypass Equipment Sales Estimates and Forecasts 2020-2031
2.4 Global Cardiopulmonary Bypass Equipment Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Cardiopulmonary Bypass Equipment Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Cardiopulmonary Bypass Equipment Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Single Roller Pump Cardiopulmonary Bypass Equipment Market Size by Manufacturers
3.5.2 Double Roller Pump Cardiopulmonary Bypass Equipment Market Size by Manufacturers
3.6 Global Cardiopulmonary Bypass Equipment Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Cardiopulmonary Bypass Equipment Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Cardiopulmonary Bypass Equipment Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Cardiopulmonary Bypass Equipment Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Cardiopulmonary Bypass Equipment Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Cardiopulmonary Bypass Equipment Sales and Revenue by Type (2020-2031)
6.4 North America Cardiopulmonary Bypass Equipment Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Cardiopulmonary Bypass Equipment Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Cardiopulmonary Bypass Equipment Sales and Revenue by Type (2020-2031)
7.4 Europe Cardiopulmonary Bypass Equipment Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Cardiopulmonary Bypass Equipment Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Cardiopulmonary Bypass Equipment Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Cardiopulmonary Bypass Equipment Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Cardiopulmonary Bypass Equipment Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Cardiopulmonary Bypass Equipment Sales and Revenue by Type (2020-2031)
9.4 Central and South America Cardiopulmonary Bypass Equipment Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Cardiopulmonary Bypass Equipment Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Cardiopulmonary Bypass Equipment Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Cardiopulmonary Bypass Equipment Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Cardiopulmonary Bypass Equipment Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Sorin
11.1.1 Sorin Corporation Information
11.1.2 Sorin Business Overview
11.1.3 Sorin Cardiopulmonary Bypass Equipment Product Models, Descriptions and Specifications
11.1.4 Sorin Cardiopulmonary Bypass Equipment Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Sorin Cardiopulmonary Bypass Equipment Sales by Product in 2024
11.1.6 Sorin Cardiopulmonary Bypass Equipment Sales by Application in 2024
11.1.7 Sorin Cardiopulmonary Bypass Equipment Sales by Geographic Area in 2024
11.1.8 Sorin Cardiopulmonary Bypass Equipment SWOT Analysis
11.1.9 Sorin Recent Developments
11.2 MAQUET
11.2.1 MAQUET Corporation Information
11.2.2 MAQUET Business Overview
11.2.3 MAQUET Cardiopulmonary Bypass Equipment Product Models, Descriptions and Specifications
11.2.4 MAQUET Cardiopulmonary Bypass Equipment Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 MAQUET Cardiopulmonary Bypass Equipment Sales by Product in 2024
11.2.6 MAQUET Cardiopulmonary Bypass Equipment Sales by Application in 2024
11.2.7 MAQUET Cardiopulmonary Bypass Equipment Sales by Geographic Area in 2024
11.2.8 MAQUET Cardiopulmonary Bypass Equipment SWOT Analysis
11.2.9 MAQUET Recent Developments
11.3 Medtronic
11.3.1 Medtronic Corporation Information
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Cardiopulmonary Bypass Equipment Product Models, Descriptions and Specifications
11.3.4 Medtronic Cardiopulmonary Bypass Equipment Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Medtronic Cardiopulmonary Bypass Equipment Sales by Product in 2024
11.3.6 Medtronic Cardiopulmonary Bypass Equipment Sales by Application in 2024
11.3.7 Medtronic Cardiopulmonary Bypass Equipment Sales by Geographic Area in 2024
11.3.8 Medtronic Cardiopulmonary Bypass Equipment SWOT Analysis
11.3.9 Medtronic Recent Developments
11.4 Terumo
11.4.1 Terumo Corporation Information
11.4.2 Terumo Business Overview
11.4.3 Terumo Cardiopulmonary Bypass Equipment Product Models, Descriptions and Specifications
11.4.4 Terumo Cardiopulmonary Bypass Equipment Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Terumo Cardiopulmonary Bypass Equipment Sales by Product in 2024
11.4.6 Terumo Cardiopulmonary Bypass Equipment Sales by Application in 2024
11.4.7 Terumo Cardiopulmonary Bypass Equipment Sales by Geographic Area in 2024
11.4.8 Terumo Cardiopulmonary Bypass Equipment SWOT Analysis
11.4.9 Terumo Recent Developments
11.5 Braile Biomedica
11.5.1 Braile Biomedica Corporation Information
11.5.2 Braile Biomedica Business Overview
11.5.3 Braile Biomedica Cardiopulmonary Bypass Equipment Product Models, Descriptions and Specifications
11.5.4 Braile Biomedica Cardiopulmonary Bypass Equipment Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Braile Biomedica Cardiopulmonary Bypass Equipment Sales by Product in 2024
11.5.6 Braile Biomedica Cardiopulmonary Bypass Equipment Sales by Application in 2024
11.5.7 Braile Biomedica Cardiopulmonary Bypass Equipment Sales by Geographic Area in 2024
11.5.8 Braile Biomedica Cardiopulmonary Bypass Equipment SWOT Analysis
11.5.9 Braile Biomedica Recent Developments
11.6 Tianjin Medical
11.6.1 Tianjin Medical Corporation Information
11.6.2 Tianjin Medical Business Overview
11.6.3 Tianjin Medical Cardiopulmonary Bypass Equipment Product Models, Descriptions and Specifications
11.6.4 Tianjin Medical Cardiopulmonary Bypass Equipment Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Tianjin Medical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Cardiopulmonary Bypass Equipment Industry Chain
12.2 Cardiopulmonary Bypass Equipment Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Cardiopulmonary Bypass Equipment Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Cardiopulmonary Bypass Equipment Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Cardiopulmonary Bypass Equipment Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Cardiopulmonary Bypass Equipment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Cardiopulmonary Bypass Equipment Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Cardiopulmonary Bypass Equipment Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Cardiopulmonary Bypass Equipment Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Cardiopulmonary Bypass Equipment Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Cardiopulmonary Bypass Equipment Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Cardiopulmonary Bypass Equipment Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global Cardiopulmonary Bypass Equipment Sales by Region (2020-2025) & (Units)
Table 8. Global Cardiopulmonary Bypass Equipment Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Cardiopulmonary Bypass Equipment Sales by Manufacturers (2020-2025) & (Units)
Table 11. Global Cardiopulmonary Bypass Equipment Sales Share by Manufacturers (2020-2025)
Table 12. Global Cardiopulmonary Bypass Equipment Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Cardiopulmonary Bypass Equipment Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Cardiopulmonary Bypass Equipment by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiopulmonary Bypass Equipment as of 2024)
Table 16. Global Cardiopulmonary Bypass Equipment Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Cardiopulmonary Bypass Equipment Average Selling Price (ASP) by Manufacturers (2020-2025) & (K USD/Unit)
Table 18. Key Manufacturers Cardiopulmonary Bypass Equipment Manufacturing Base and Headquarters
Table 19. Global Cardiopulmonary Bypass Equipment Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Cardiopulmonary Bypass Equipment Sales by Type (2020-2025) & (Units)
Table 23. Global Cardiopulmonary Bypass Equipment Sales by Type (2026-2031) & (Units)
Table 24. Global Cardiopulmonary Bypass Equipment Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Cardiopulmonary Bypass Equipment Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Cardiopulmonary Bypass Equipment ASP by Type (2020-2031) & (K USD/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Cardiopulmonary Bypass Equipment Sales by Application (2020-2025) & (Units)
Table 29. Global Cardiopulmonary Bypass Equipment Sales by Application (2026-2031) & (Units)
Table 30. Cardiopulmonary Bypass Equipment High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Cardiopulmonary Bypass Equipment Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Cardiopulmonary Bypass Equipment Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Cardiopulmonary Bypass Equipment ASP by Application (2020-2031) & (K USD/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Cardiopulmonary Bypass Equipment Growth Accelerators and Market Barriers
Table 37. North America Cardiopulmonary Bypass Equipment Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Cardiopulmonary Bypass Equipment Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Cardiopulmonary Bypass Equipment Growth Accelerators and Market Barriers
Table 40. Europe Cardiopulmonary Bypass Equipment Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Cardiopulmonary Bypass Equipment Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Cardiopulmonary Bypass Equipment Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Cardiopulmonary Bypass Equipment Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Cardiopulmonary Bypass Equipment Growth Accelerators and Market Barriers
Table 45. Southeast Asia Cardiopulmonary Bypass Equipment Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Cardiopulmonary Bypass Equipment Investment Opportunities and Key Challenges
Table 47. Central and South America Cardiopulmonary Bypass Equipment Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Cardiopulmonary Bypass Equipment Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Cardiopulmonary Bypass Equipment Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Sorin Corporation Information
Table 51. Sorin Description and Major Businesses
Table 52. Sorin Product Models, Descriptions and Specifications
Table 53. Sorin Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 54. Sorin Sales Value Proportion by Product in 2024
Table 55. Sorin Sales Value Proportion by Application in 2024
Table 56. Sorin Sales Value Proportion by Geographic Area in 2024
Table 57. Sorin Cardiopulmonary Bypass Equipment SWOT Analysis
Table 58. Sorin Recent Developments
Table 59. MAQUET Corporation Information
Table 60. MAQUET Description and Major Businesses
Table 61. MAQUET Product Models, Descriptions and Specifications
Table 62. MAQUET Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 63. MAQUET Sales Value Proportion by Product in 2024
Table 64. MAQUET Sales Value Proportion by Application in 2024
Table 65. MAQUET Sales Value Proportion by Geographic Area in 2024
Table 66. MAQUET Cardiopulmonary Bypass Equipment SWOT Analysis
Table 67. MAQUET Recent Developments
Table 68. Medtronic Corporation Information
Table 69. Medtronic Description and Major Businesses
Table 70. Medtronic Product Models, Descriptions and Specifications
Table 71. Medtronic Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 72. Medtronic Sales Value Proportion by Product in 2024
Table 73. Medtronic Sales Value Proportion by Application in 2024
Table 74. Medtronic Sales Value Proportion by Geographic Area in 2024
Table 75. Medtronic Cardiopulmonary Bypass Equipment SWOT Analysis
Table 76. Medtronic Recent Developments
Table 77. Terumo Corporation Information
Table 78. Terumo Description and Major Businesses
Table 79. Terumo Product Models, Descriptions and Specifications
Table 80. Terumo Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 81. Terumo Sales Value Proportion by Product in 2024
Table 82. Terumo Sales Value Proportion by Application in 2024
Table 83. Terumo Sales Value Proportion by Geographic Area in 2024
Table 84. Terumo Cardiopulmonary Bypass Equipment SWOT Analysis
Table 85. Terumo Recent Developments
Table 86. Braile Biomedica Corporation Information
Table 87. Braile Biomedica Description and Major Businesses
Table 88. Braile Biomedica Product Models, Descriptions and Specifications
Table 89. Braile Biomedica Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 90. Braile Biomedica Sales Value Proportion by Product in 2024
Table 91. Braile Biomedica Sales Value Proportion by Application in 2024
Table 92. Braile Biomedica Sales Value Proportion by Geographic Area in 2024
Table 93. Braile Biomedica Cardiopulmonary Bypass Equipment SWOT Analysis
Table 94. Braile Biomedica Recent Developments
Table 95. Tianjin Medical Corporation Information
Table 96. Tianjin Medical Description and Major Businesses
Table 97. Tianjin Medical Product Models, Descriptions and Specifications
Table 98. Tianjin Medical Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 99. Tianjin Medical Recent Developments
Table 100. Key Raw Materials Distribution
Table 101. Raw Materials Key Suppliers
Table 102. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 103. Milestones in Production Technology Evolution
Table 104. Distributors List
Table 105. Market Trends and Market Evolution
Table 106. Market Drivers and Opportunities
Table 107. Market Challenges, Risks, and Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Cardiopulmonary Bypass Equipment Product Picture
Figure 2. Global Cardiopulmonary Bypass Equipment Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Single Roller Pump Cardiopulmonary Bypass Equipment Product Picture
Figure 4. Double Roller Pump Cardiopulmonary Bypass Equipment Product Picture
Figure 5. Global Cardiopulmonary Bypass Equipment Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Cardiac Surgery
Figure 7. Lung Transplant Operation
Figure 8. Acute Respiratory Failure Treatment
Figure 9. Others
Figure 10. Cardiopulmonary Bypass Equipment Report Years Considered
Figure 11. Global Cardiopulmonary Bypass Equipment Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Cardiopulmonary Bypass Equipment Revenue (2020-2031) & (US$ Million)
Figure 13. Global Cardiopulmonary Bypass Equipment Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Cardiopulmonary Bypass Equipment Revenue Market Share by Region (2020-2031)
Figure 15. Global Cardiopulmonary Bypass Equipment Sales (2020-2031) & (Units)
Figure 16. Global Cardiopulmonary Bypass Equipment Sales (CAGR) by Region (2020-2031) (Units)
Figure 17. Global Cardiopulmonary Bypass Equipment Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Cardiopulmonary Bypass Equipment Sales Volume Market Share in 2024
Figure 19. Global Cardiopulmonary Bypass Equipment Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Single Roller Pump Cardiopulmonary Bypass Equipment Revenue Market Share by Manufacturer in 2024
Figure 22. Double Roller Pump Cardiopulmonary Bypass Equipment Revenue Market Share by Manufacturer in 2024
Figure 23. Global Cardiopulmonary Bypass Equipment Sales Market Share by Type (2020-2031)
Figure 24. Global Cardiopulmonary Bypass Equipment Revenue Market Share by Type (2020-2031)
Figure 25. Global Cardiopulmonary Bypass Equipment Sales Market Share by Application (2020-2031)
Figure 26. Global Cardiopulmonary Bypass Equipment Revenue Market Share by Application (2020-2031)
Figure 27. North America Cardiopulmonary Bypass Equipment Sales YoY (2020-2031) & (Units)
Figure 28. North America Cardiopulmonary Bypass Equipment Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Manufacturers Cardiopulmonary Bypass Equipment Sales Revenue (US$ Million) in 2024
Figure 30. North America Cardiopulmonary Bypass Equipment Sales Volume (Units) by Type (2020- 2031)
Figure 31. North America Cardiopulmonary Bypass Equipment Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America Cardiopulmonary Bypass Equipment Sales Volume (Units) by Application (2020-2031)
Figure 33. North America Cardiopulmonary Bypass Equipment Sales Revenue (US$ Million) by Application (2020-2031)
Figure 34. US Cardiopulmonary Bypass Equipment Revenue (2020-2031) & (US$ Million)
Figure 35. Canada Cardiopulmonary Bypass Equipment Revenue (2020-2031) & (US$ Million)
Figure 36. Mexico Cardiopulmonary Bypass Equipment Revenue (2020-2031) & (US$ Million)
Figure 37. Europe Cardiopulmonary Bypass Equipment Sales YoY (2020-2031) & (Units)
Figure 38. Europe Cardiopulmonary Bypass Equipment Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Europe Top 5 Manufacturers Cardiopulmonary Bypass Equipment Sales Revenue (US$ Million) in 2024
Figure 40. Europe Cardiopulmonary Bypass Equipment Sales Volume (Units) by Type (2020-2031)
Figure 41. Europe Cardiopulmonary Bypass Equipment Sales Revenue (US$ Million) by Type (2020-2031)
Figure 42. Europe Cardiopulmonary Bypass Equipment Sales Volume (Units) by Application (2020-2031)
Figure 43. Europe Cardiopulmonary Bypass Equipment Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. Germany Cardiopulmonary Bypass Equipment Revenue (2020-2031) & (US$ Million)
Figure 45. France Cardiopulmonary Bypass Equipment Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. Cardiopulmonary Bypass Equipment Revenue (2020-2031) & (US$ Million)
Figure 47. Italy Cardiopulmonary Bypass Equipment Revenue (2020-2031) & (US$ Million)
Figure 48. Russia Cardiopulmonary Bypass Equipment Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Cardiopulmonary Bypass Equipment Sales YoY (2020-2031) & (Units)
Figure 50. Asia-Pacific Cardiopulmonary Bypass Equipment Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Top 8 Manufacturers Cardiopulmonary Bypass Equipment Sales Revenue (US$ Million) in 2024
Figure 52. Asia-Pacific Cardiopulmonary Bypass Equipment Sales Volume (Units) by Type (2020- 2031)
Figure 53. Asia-Pacific Cardiopulmonary Bypass Equipment Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 54. Asia-Pacific Cardiopulmonary Bypass Equipment Sales Volume (Units) by Application (2020-2031)
Figure 55. Asia-Pacific Cardiopulmonary Bypass Equipment Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Indonesia Cardiopulmonary Bypass Equipment Revenue (2020-2031) & (US$ Million)
Figure 57. Japan Cardiopulmonary Bypass Equipment Revenue (2020-2031) & (US$ Million)
Figure 58. South Korea Cardiopulmonary Bypass Equipment Revenue (2020-2031) & (US$ Million)
Figure 59. China Taiwan Cardiopulmonary Bypass Equipment Revenue (2020-2031) & (US$ Million)
Figure 60. India Cardiopulmonary Bypass Equipment Revenue (2020-2031) & (US$ Million)
Figure 61. Central and South America Cardiopulmonary Bypass Equipment Sales YoY (2020-2031) & (Units)
Figure 62. Central and South America Cardiopulmonary Bypass Equipment Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Central and South America Top 5 Manufacturers Cardiopulmonary Bypass Equipment Sales Revenue (US$ Million) in 2024
Figure 64. Central and South America Cardiopulmonary Bypass Equipment Sales Volume (Units) by Type (2021-2031)
Figure 65. Central and South America Cardiopulmonary Bypass Equipment Sales Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America Cardiopulmonary Bypass Equipment Sales Volume (Units) by Application (2020-2031)
Figure 67. Central and South America Cardiopulmonary Bypass Equipment Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Brazil Cardiopulmonary Bypass Equipment Revenue (2020-2025) & (US$ Million)
Figure 69. Argentina Cardiopulmonary Bypass Equipment Revenue (2020-2025) & (US$ Million)
Figure 70. Middle East, and Africa Cardiopulmonary Bypass Equipment Sales YoY (2020-2031) & (Units)
Figure 71. Middle East and Africa Cardiopulmonary Bypass Equipment Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Middle East and Africa Top 5 Manufacturers Cardiopulmonary Bypass Equipment Sales Revenue (US$ Million) in 2024
Figure 73. Middle East and Africa Cardiopulmonary Bypass Equipment Sales Volume (Units) by Type (2021-2031)
Figure 74. South America Cardiopulmonary Bypass Equipment Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Middle East and Africa Cardiopulmonary Bypass Equipment Sales Volume (Units) by Application (2020-2031)
Figure 76. Middle East and Africa Cardiopulmonary Bypass Equipment Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. GCC Countries Cardiopulmonary Bypass Equipment Revenue (2020-2025) & (US$ Million)
Figure 78. Turkey Cardiopulmonary Bypass Equipment Revenue (2020-2025) & (US$ Million)
Figure 79. Egypt Cardiopulmonary Bypass Equipment Revenue (2020-2025) & (US$ Million)
Figure 80. South Africa Cardiopulmonary Bypass Equipment Revenue (2020-2025) & (US$ Million)
Figure 81. Cardiopulmonary Bypass Equipment Industry Chain Mapping
Figure 82. Regional Cardiopulmonary Bypass Equipment Manufacturing Base Distribution (%)
Figure 83. Global Cardiopulmonary Bypass Equipment Production Market Share by Region (2020-2031)
Figure 84. Cardiopulmonary Bypass Equipment Production Process
Figure 85. Regional Cardiopulmonary Bypass Equipment Production Cost Structure
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Cardiopulmonary Bypass Equipment market?
The top companies in the global Cardiopulmonary Bypass Equipment market are Sorin、MAQUET、Medtronic.
Which region is expected to have the highest market share?
What was the global market size of Cardiopulmonary Bypass Equipment in 2025?
What was the global market size of Cardiopulmonary Bypass Equipment in 2031?
What is the annual compound growth rate of the global Cardiopulmonary Bypass Equipment market size from 2025 to 2031?
Related Reports
Global Cardiopulmonary Bypass Equipment Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cardiopulmonary Bypass Equipment market is projected to grow from US$ 550 million in 2025 to US$ 1042 million by 2032, at a CAGR of 9.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-07-11
Pages: 139
USD 4900.00
(Single User License)
Global Cardiopulmonary Bypass Equipment Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cardiopulmonary Bypass Equipment market size was US$ 550 million in 2025 and is forecast to reach a readjusted size of US$ 1042 million by 2032 with a CAGR of 9.7% during the forecast period 2026-2032.
Published Date: 2026-07-11
Pages: 128
USD 4250.00
(Single User License)
Global Cardiopulmonary Bypass Equipment Market Research Report 2026
The global Cardiopulmonary Bypass Equipment market was valued at US$ 550 million in 2025 and is anticipated to reach US$ 1042 million by 2032, at a CAGR of 9.7% from 2026 to 2032.
Published Date: 2026-07-11
Pages: 114
USD 2900.00
(Single User License)
Cardiopulmonary Bypass Equipment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cardiopulmonary Bypass Equipment was estimated to be worth US$ 550 million in 2025 and is projected to reach US$ 1042 million, growing at a CAGR of 9.7% from 2026 to 2032.
Published Date: 2026-07-11
Pages: 132
USD 3950.00
(Single User License)
Global Cardiopulmonary Bypass Equipment Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Cardiopulmonary Bypass Equipment was estimated to be worth US$ 506 million and is forecast to reach approximately US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 123
USD 5900.00
(Single User License)
Global Cardiopulmonary Bypass Equipment Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cardiopulmonary Bypass Equipment market size was US$ 506 million in 2024 and is forecast to a readjusted size of US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 77
USD 4250.00
(Single User License)
Cardiopulmonary Bypass Equipment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cardiopulmonary Bypass Equipment was estimated to be worth US$ 506 million in 2024 and is forecast to a readjusted size of US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 109
USD 3950.00
(Single User License)
Global Cardiopulmonary Bypass Equipment Market Research Report 2025
The global market for Cardiopulmonary Bypass Equipment was valued at US$ 506 million in the year 2024 and is projected to reach a revised size of US$ 959 million by 2031, growing at a CAGR of 9.7% during the forecast period.
Published Date: 2025-01-16
Pages: 83
USD 2900.00
(Single User License)
Global Cardiopulmonary Bypass Equipment Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Cardiopulmonary Bypass Equipment is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The Cardiopulmonary Bypass Equipment is also called a heart-lung machine. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Published Date: 2024-04-17
Pages: 146
USD 5600.00
(Single User License)
Global Cardiopulmonary Bypass Equipment Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Cardiopulmonary Bypass Equipment is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The Cardiopulmonary Bypass Equipment is also called a heart-lung machine. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Published Date: 2024-04-16
Pages: 123
USD 5900.00
(Single User License)
Global Cardiopulmonary Bypass Equipment Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cardiopulmonary Bypass Equipment market is projected to grow from US$ 550 million in 2025 to US$ 1042 million by 2032, at a CAGR of 9.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-07-11
Pages: 139
USD 4900.00 (Single User License)Global Cardiopulmonary Bypass Equipment Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cardiopulmonary Bypass Equipment market size was US$ 550 million in 2025 and is forecast to reach a readjusted size of US$ 1042 million by 2032 with a CAGR of 9.7% during the forecast period 2026-2032.
Published: 2026-07-11
Pages: 128
USD 4250.00 (Single User License)Global Cardiopulmonary Bypass Equipment Market Research Report 2026
The global Cardiopulmonary Bypass Equipment market was valued at US$ 550 million in 2025 and is anticipated to reach US$ 1042 million by 2032, at a CAGR of 9.7% from 2026 to 2032.
Published: 2026-07-11
Pages: 114
USD 2900.00 (Single User License)Cardiopulmonary Bypass Equipment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cardiopulmonary Bypass Equipment was estimated to be worth US$ 550 million in 2025 and is projected to reach US$ 1042 million, growing at a CAGR of 9.7% from 2026 to 2032.
Published: 2026-07-11
Pages: 132
USD 3950.00 (Single User License)Global Cardiopulmonary Bypass Equipment Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Cardiopulmonary Bypass Equipment was estimated to be worth US$ 506 million and is forecast to reach approximately US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 123
USD 5900.00 (Single User License)Global Cardiopulmonary Bypass Equipment Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cardiopulmonary Bypass Equipment market size was US$ 506 million in 2024 and is forecast to a readjusted size of US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 77
USD 4250.00 (Single User License)Cardiopulmonary Bypass Equipment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cardiopulmonary Bypass Equipment was estimated to be worth US$ 506 million in 2024 and is forecast to a readjusted size of US$ 959 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 109
USD 3950.00 (Single User License)Global Cardiopulmonary Bypass Equipment Market Research Report 2025
The global market for Cardiopulmonary Bypass Equipment was valued at US$ 506 million in the year 2024 and is projected to reach a revised size of US$ 959 million by 2031, growing at a CAGR of 9.7% during the forecast period.
Published: 2025-01-16
Pages: 83
USD 2900.00 (Single User License)Global Cardiopulmonary Bypass Equipment Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Cardiopulmonary Bypass Equipment is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The Cardiopulmonary Bypass Equipment is also called a heart-lung machine. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Published: 2024-04-17
Pages: 146
USD 5600.00 (Single User License)Global Cardiopulmonary Bypass Equipment Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Cardiopulmonary Bypass Equipment is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The Cardiopulmonary Bypass Equipment is also called a heart-lung machine. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Published: 2024-04-16
Pages: 123
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now